Wegmans Recalls TopCare Eye Drops Over Sterility Concerns

Wegmans, a grocery store chain operating in nine states, announced on September 13 that two of its TopCare brand eye drop products are being recalled by their manufacturer, TopCo. TopCo, an Illinois-based company specializing in private-label food and household goods, produces the TopCare line, which includes beauty and healthcare items. The recall notice from Wegmans cited "Potential sterility assurance concerns" as the reason for the withdrawal of these specific eye drops. This development is part of a broader trend of eye drop recalls over the past few years, driven by similar anxieties regarding inadequate sterility. These sterility concerns are critical because non-sterile eye drops can lead to serious infections, potentially causing blindness. The current recall involves two specific TopCare products, though the exact product names and lot numbers were not detailed in the initial announcement. The recall notice from Wegmans directs consumers to return the affected products to the store for a refund. This latest action follows a series of significant eye drop recalls. In May 2025, BRS Analytical Service LLC recalled approximately 76,000 cases of eye care products, also citing "unacceptable quality" and a lack of "assurance of sterility," as cautioned by the Food and Drug Administration (FDA). Earlier in April of the current year, a larger recall encompassed over 3.1 million bottles of eye drops sold under various brand names, including TopCare, CVS, Walgreens, Good Sense, and Best Choice. These products were reportedly not subjected to adequate testing to ensure their sterility. Just last month, Prestige Brands Holdings initiated a nationwide recall of 40,000 bottles of eye drops due to fears of a "heightened risk of harm" stemming from sterility issues. The recurring nature of these recalls underscores the ongoing challenges in maintaining stringent sterility standards within the pharmaceutical manufacturing sector, particularly for products intended for direct ocular application. The FDA continues to monitor these recalls and investigate the root causes of the sterility failures. Consumers are advised to check recall notices carefully and discontinue the use of any recalled eye drop products immediately.